Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas-Reference-Cited by-同舟云学术

Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas

Published:1994-05-15 Issue:10 Volume:73 Page:2515-2519
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Haim Nissim,Epelbaum Ron,Ben-Shahar Menachem,Yarnitsky David,Simri Waleed,Robinson Eliezer

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference14 articles.

1. , . Hodgkin's disease and the non-Hodgkin's lymphomas. In: , , editors. Principles and practice of oncology. Vol. 2. Philadelphia: JB Lippincott Co, 1985: 1623–709.

2. . Clinical pharmacology of cancer chemotherapy. In: , (editors). Principles and practice of oncology. Vol. 1. Philadelphia: JB Lippincott Company, 1985: 287–328.

3. Twenty years of MOPP therapy for Hodgkin's disease.

4. Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.

5. A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of vincristine-induced peripheral neuropathy by protecting the endothelial glycocalyx shedding;Biochemical and Biophysical Research Communications;2024-01

2. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies;Cancers;2023-11-02

3. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia;Clinical Neurophysiology;2023-10

4. Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy;Cancer Chemotherapy and Pharmacology;2023-08-23

5. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts;Archives of Toxicology;2022-11-23